Genetic Signatures
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAGenetic Signatures Limited (GSS) is a molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3Base™.
The company deals in the the research and commercialisation of identifying individual genetic signatures to aid in the diagnosis of infectious diseases, and the sale of associated products into the diagnostic & research marketplaces.
Contact Details
7 Eliza Street, NEWTOWN NSW 2042
02 9870 7580
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 30/09/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 400th | Genetic Signatures | 34% | -8% |
1743 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Genetic Signatures | $13.8m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Jenny Harry, Non-Executive Director | 08 Oct 2024 |
| NEW ROLE: Anne Lockwood, Non-Executive Director | 08 Oct 2024 |
| ECM DEAL: New deal has been added | 22 Jul 2024 |
| ECM DEAL: New deal has been added | 27 Feb 2024 |
| NEW ROLE: Neil Gunn, Non-Executive Director | 13 Apr 2021 |
| NEW ROLE: Douglas S Millar, | 24 Nov 2020 |
| REMUNERATION UPDATE: Michael Aicher, Executive Director - US Operations | 13 Nov 2020 |
| REMUNERATION UPDATE: Peter Manley, Chief Financial Officer, Company Secretary | 13 Nov 2020 |
| REMUNERATION UPDATE: John Melki, Chief Executive Officer, Managing Director | 13 Nov 2020 |
